What does Docteur Josse Th.Cardiologie do?

Docteur Josse Th.Cardiologie is a specialist medical practice in La Hulpe. Private Limited, started on 4 December 2007, 1 establishment.

What is the address of Docteur Josse Th.Cardiologie?

The registered office of Docteur Josse Th.Cardiologie is located at Avenue de la Corniche 6, 1310 La Hulpe.

Is Docteur Josse Th.Cardiologie still active?

Yes. According to the CBE (16 September 2026) Docteur Josse Th.Cardiologie is active, legal situation “Normale toestand”, started on 4 December 2007.

Is Docteur Josse Th.Cardiologie registered on Peppol?

Yes, Docteur Josse Th.Cardiologie is registered on the Peppol network with ID 0208:0893916168.

What is the enterprise number of Docteur Josse Th.Cardiologie?

The enterprise number of Docteur Josse Th.Cardiologie is BE0893916168.

When was Docteur Josse Th.Cardiologie founded?

Docteur Josse Th.Cardiologie was founded on 4 December 2007.

Who are the directors of Docteur Josse Th.Cardiologie?

According to the 2025 annual accounts, the directors of Docteur Josse Th.Cardiologie are: THIERRY JOSSE.

Is Docteur Josse Th.Cardiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 December 2007; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Docteur Josse Th.Cardiologie make in 2025?

Docteur Josse Th.Cardiologie posted a profit after taxes of € 81,868 in financial year 2025.

What is the revenue of Docteur Josse Th.Cardiologie?

As a small company, Docteur Josse Th.Cardiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 125,670.

Docteur Josse Th.Cardiologie (Private Limited) - La Hulpe

Dossier Docteur Josse Th.Cardiologie, printed on 16 September 2026 from databakkes.be/en/0893916168/docteur-josse-th-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Docteur Josse Th.Cardiologie from La Hulpe, company number BE0893916168, closed financial year 2025 with a result of € 81,868 after tax. For that financial year Docteur Josse Th.Cardiologie recorded a gross margin of € 125,670 and equity of € 390,732. Compared with financial year 2024, the result moved from € 87,479 to € 81,868. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.

What it is worth Growing

€ 390,732

▲ 27% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 81,868

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 250,316

▲ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,710 paid out

62 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 7,178

▲ 115% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 30,515

▼ 29% vs 2024

€ 13,819 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 3,157

▲ € 2,531 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,077

▼ 95% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 43,929 Gross margin 2022: € 43,929 First fiscal year in the series	€ 100,014 Gross margin 2023: € 100,014 ▲ 128% vs 2022 (€ 43,929) Favourable step	€ 141,637 Gross margin 2024: € 141,637 ▲ 42% vs 2023 (€ 100,014) Favourable step	€ 125,670 Gross margin 2025: € 125,670 ▼ 11% vs 2024 (€ 141,637) Unfavourable step	▼ 11%
Profit after taxes	€ 18,587 Profit after taxes 2022: € 18,587 First fiscal year in the series	€ 56,731 Profit after taxes 2023: € 56,731 ▲ 205% vs 2022 (€ 18,587) Favourable step	€ 87,479 Profit after taxes 2024: € 87,479 ▲ 54% vs 2023 (€ 56,731) Favourable step	€ 81,868 Profit after taxes 2025: € 81,868 ▼ 6% vs 2024 (€ 87,479) Unfavourable step	▼ 6%
Equity	€ 164,654 Equity 2022: € 164,654 First fiscal year in the series	€ 221,385 Equity 2023: € 221,385 ▲ 34% vs 2022 (€ 164,654) Favourable step	€ 308,865 Equity 2024: € 308,865 ▲ 40% vs 2023 (€ 221,385) Favourable step	€ 390,732 Equity 2025: € 390,732 ▲ 27% vs 2024 (€ 308,865) Favourable step	▲ 27%
Total debts	€ 142,949 Total debts 2022: € 142,949 First fiscal year in the series	€ 136,107 Total debts 2023: € 136,107 ▼ 5% vs 2022 (€ 142,949) Favourable step	€ 135,115 Total debts 2024: € 135,115 ▼ 1% vs 2023 (€ 136,107) Favourable step	€ 106,849 Total debts 2025: € 106,849 ▼ 21% vs 2024 (€ 135,115) Favourable step	▼ 21%
Cash	€ 86,739 Cash 2022: € 86,739 First fiscal year in the series	€ 134,695 Cash 2023: € 134,695 ▲ 55% vs 2022 (€ 86,739) Favourable step	€ 213,849 Cash 2024: € 213,849 ▲ 59% vs 2023 (€ 134,695) Favourable step	€ 250,316 Cash 2025: € 250,316 ▲ 17% vs 2024 (€ 213,849) Favourable step	▲ 17%
Land & buildings	€ 41,271 Land & buildings 2022: € 41,271 First fiscal year in the series	€ 33,136 Land & buildings 2023: € 33,136 ▼ 20% vs 2022 (€ 41,271) Unchanged	€ 25,001 Land & buildings 2024: € 25,001 ▼ 25% vs 2023 (€ 33,136) Unchanged	€ 16,867 Land & buildings 2025: € 16,867 ▼ 33% vs 2024 (€ 25,001) Unchanged	▼ 33%
Retained profit	€ 102,254 Retained profit 2022: € 102,254 First fiscal year in the series	€ 158,985 Retained profit 2023: € 158,985 ▲ 55% vs 2022 (€ 102,254) Favourable step	€ 246,465 Retained profit 2024: € 246,465 ▲ 55% vs 2023 (€ 158,985) Favourable step	€ 321,472 Retained profit 2025: € 321,472 ▲ 30% vs 2024 (€ 246,465) Favourable step	▲ 30%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 50,710 Dividend 2025: € 50,710 Unchanged (€ 0) Unchanged
Bank debt	€ 65,842 Bank debt 2022: € 65,842 First fiscal year in the series	€ 54,528 Bank debt 2023: € 54,528 ▼ 17% vs 2022 (€ 65,842) Favourable step	€ 42,758 Bank debt 2024: € 42,758 ▼ 22% vs 2023 (€ 54,528) Favourable step	€ 30,515 Bank debt 2025: € 30,515 ▼ 29% vs 2024 (€ 42,758) Favourable step	▼ 29%
Balance sheet total	€ 307,603 Balance sheet total 2022: € 307,603 First fiscal year in the series	€ 357,492 Balance sheet total 2023: € 357,492 ▲ 16% vs 2022 (€ 307,603) Unchanged	€ 443,980 Balance sheet total 2024: € 443,980 ▲ 24% vs 2023 (€ 357,492) Unchanged	€ 497,582 Balance sheet total 2025: € 497,582 ▲ 12% vs 2024 (€ 443,980) Unchanged	▲ 12%

Key figures of Docteur Josse Th.Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Docteur Josse Th.Cardiologie?

What happened at Docteur Josse Th.Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 30, 2026 New annual accounts for financial year 2025: profit of € 81,868 (▼ 6% vs 2024). Source: NBB ↗
Dec 4, 2007 New establishment in Sint-Pieters-Woluwe. KBO
Dec 4, 2007 Start of the company according to the CBE. KBO
2007 THIERRY JOSSE became a director. NBB

In short

From € 18,587 profit in 2022 to € 81,868 profit in 2025.

Paid € 115,054 in corporate taxes since 2022.

Best year ever: 2024, with € 87,479 profit.

Paid out € 50,710 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Docteur Josse Th.Cardiologie? We notify you, reason included.

Follow Docteur Josse Th.Cardiologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

THIERRY JOSSE

Docteur Josse Th.Cardiologie

Behind Docteur Josse Th.Cardiologie is THIERRY JOSSE.

See the full network in the app

Directors

According to the 2025 annual accounts

THIERRY JOSSE

Manager

since 2007

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue de la Corniche 6

1310 La Hulpe

2.303.146.620

Kapitein Piretlaan 67

1150 Sint-Pieters-Woluwe

Active since 4 December 2007

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SOTY

€ 66,737 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0893.916.168
VAT number: BE 0893.916.168
Registered office: Avenue de la Corniche 6, 1310 La Hulpe
Names & denominations: Docteur Josse Th.Cardiologie · J.T.C.
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 December 2007
Peppol: Active · Active since 15 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗